- Home
- PGEN vs SMTI Comparison
PGEN vs SMTI Comparison
Compare PGEN & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- SMTI
- Stock Information
- Founded
- PGEN 1998
- SMTI 1982
- Country
- PGEN United States
- SMTI United States
- Employees
- PGEN N/A
- SMTI N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- SMTI Medical/Dental Instruments
- Sector
- PGEN Health Care
- SMTI Health Care
- Exchange
- PGEN Nasdaq
- SMTI Nasdaq
- Market Cap
- PGEN 292.6M
- SMTI 288.2M
- IPO Year
- PGEN N/A
- SMTI N/A
- Fundamental
- Price
- PGEN $0.74
- SMTI $34.20
- Analyst Decision
- PGEN Buy
- SMTI Strong Buy
- Analyst Count
- PGEN 5
- SMTI 2
- Target Price
- PGEN $7.00
- SMTI $47.00
- AVG Volume (30 Days)
- PGEN 1.1M
- SMTI 31.6K
- Earning Date
- PGEN 11-14-2024
- SMTI 11-12-2024
- Dividend Yield
- PGEN N/A
- SMTI N/A
- EPS Growth
- PGEN N/A
- SMTI N/A
- EPS
- PGEN N/A
- SMTI N/A
- Revenue
- PGEN $3,963,000.00
- SMTI $78,056,873.00
- Revenue This Year
- PGEN N/A
- SMTI $29.95
- Revenue Next Year
- PGEN $402.12
- SMTI $19.68
- P/E Ratio
- PGEN N/A
- SMTI N/A
- Revenue Growth
- PGEN N/A
- SMTI 24.66
- 52 Week Low
- PGEN $0.65
- SMTI $26.00
- 52 Week High
- PGEN $1.93
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- PGEN 43.78
- SMTI 47.55
- Support Level
- PGEN $0.71
- SMTI $31.13
- Resistance Level
- PGEN $0.78
- SMTI $35.08
- Average True Range (ATR)
- PGEN 0.05
- SMTI 1.84
- MACD
- PGEN 0.01
- SMTI -0.17
- Stochastic Oscillator
- PGEN 49.28
- SMTI 48.19
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.